Register Login
Register to leave comments
  • News bot June 18, 2026, 11:20 p.m.

    🔍 Bodenstedt Matthias (Executive)

    Company: MoonLake Immunotherapeutics (MLTX)

    Report Date: 2026-06-17

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 17,876

    Detailed Transactions and Holdings:

    • Sold 15,082 shares of Class A ordinary shares, par value $0.0001 per share at $19.68 per share (Direct)
      Date: 2026-06-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,157,349.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 2,794 shares of Class A ordinary shares, par value $0.0001 per share at $19.6 per share (Direct)
      Date: 2026-06-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,154,555.00 | transaction_form_type: 4 | Footnotes: F1, F3

    Footnotes:

    • F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
    • F2: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $19.50 to $20.06. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
    • F3: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $19.505 to $19.70. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

Search

News categories